WO1989005165A1 - Improved vascular dilation catheter construction - Google Patents

Improved vascular dilation catheter construction Download PDF

Info

Publication number
WO1989005165A1
WO1989005165A1 PCT/US1988/004384 US8804384W WO8905165A1 WO 1989005165 A1 WO1989005165 A1 WO 1989005165A1 US 8804384 W US8804384 W US 8804384W WO 8905165 A1 WO8905165 A1 WO 8905165A1
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
balloon
dilation
vascular
tube
Prior art date
Application number
PCT/US1988/004384
Other languages
French (fr)
Inventor
Richard L. Mueller
Gerri Chatelain
Richard Jaraczewski
Original Assignee
Devices For Vascular Intervention, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devices For Vascular Intervention, Inc. filed Critical Devices For Vascular Intervention, Inc.
Publication of WO1989005165A1 publication Critical patent/WO1989005165A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0119Eversible catheters

Definitions

  • the present invention relates generally to the construction of dilation catheters for angioplastic treatment of obstructed blood vessels, and more particularly to an improved catheter construction wherein a sheath envelopes a flexible catheter tube to define both a dilation balloon at a distal end of the tube and an annular lumen connecting the balloon to a proximate end of the tube.
  • Balloon angioplasty was first described by Andreas Gruntzig in 1977. Dr. Gruntzig employed a balloon-tipped flexible catheter to percutaneously dilate a region of stenosis within the coronary artery of a patient with atherosclerotic coronary artery disease. Since the original work, the use of percutaneous balloon angioplasty has become widespread, with treatment of occluded peripheral blood vessels as well as coronary arteries.
  • a common type of dilation catheter consists of a pair of coaxial tubes which are sealed together at a distal end.
  • the outer tube is expanded to form a balloon near a distal end of the catheter and a narrow annular lumen extends from the balloon to a proximate end.
  • a fitting is secured to the proximate end, allowing for the infusion of an inflation medium through the annular lumen to the balloon.
  • the catheter may be inserted over a guidewire to the desired location within a blood vessel, and inflated to dilate a stenosed region by now well known techniques.
  • the dilation catheter construction just described suffers from several drawbacks. In particular, the need to seal the outer tube to the inner catheter tube limits the choice of materials 5 available for both tubes.
  • coaxial balloon catheters are difficult to bond to other materials suitable for the inner tube.
  • most 0 coaxial balloon catheters either avoid the use of such materials, compromise on the material used for the inner tube, or provide elaborate means for sealing the distal end.
  • the seam at the bonded end will be subject to *5 failure when the catheter is use. Inflation pressures on the order of 80 to 260 psi are common, and bursting of the catheter could result in serious complications.
  • coaxial catheter constructions have typically included a rigid segment having a length on the order 0 of l cm at the distal tip of the catheter.
  • Such a 1 rigid tip can, when the adjacent balloon is inflated, be pressed against the vessel wall. During the treatment of particularly tortuous vessels and/or with very high dilation pressures, the rigid tip can * -' sometimes puncture the vessel wall. Finally, the construction methods employed in fabricating conventional dilation catheters are problematic and time consuming, increasing both the cost of production and the difficulty of meeting product specifications.
  • various approaches have been proposed for the thermal ablation of vascular obstructions, including the use of direct laser radiation and heated contact elements. Although such techniques would be free from certain 5 drawbacks of conventional balloon angioplasty, including restenosis and abrupt reclosure of the blood vessel, they suffer from their own disadvantages. Specifically, direct laser radiation can accidentally pierce the blood vessel wall, and it is often difficult to contact a heated element against the desired region of stenosis, particularly when the stenosis is non-uniformly distributed around the blood vessel.
  • Heating the inflation medium within balloons has been proposed as a method for remolding dissections which occur during conventional angioplasty, causing restenosis and abrupt reclosure. Heating for such remolding generally is carried out at lower temperatures than for ablation.
  • dilation catheters and methods for fabricating dilation catheters which do not require bonding between an inner tube and an outer tube, as described above, and which are free from rigid sealing segments at their distal ends.
  • such methods allow for a wider selection of catheter materials and simplify the fabrication process to both reduce the cost of the process and provide for improved product quality.
  • dilation catheters could be used in methods for the thermal ablation of vascular obstructions where the inflation medium within the balloon is heated to relatively high temperatures.
  • the vascular dilation catheters comprise a continuous, involuted structure including outer and inner tubular walls which are joined without seams at a distal end thereof.
  • the outer tubular wall is expanded near the distal end to define the dilation balloon.
  • the inner tubular wall further includes a separate flexible reinforcement tube with a sheath extending over both the internal and external surfaces of the reinforcement tube to complete the involuted structure. The sheath is folded over a distal end of the flexible reinforcement tube and is expanded at or near the distal end to define a dilation balloon.
  • the entire dilation balloon is thus _ completely free from seams and seals which are subject to failure and limit the choice of usable materials.
  • the fabrication method is particularly convenient, inexpensive, and provides very high product quality.
  • the outer tubular wall is spaced-apart from the external surface of the inner tubular wall to define an annular lumen along the entire length from the balloon to the proximate end of the catheter.
  • the annular lumen provides an inlet conduit for inflation medium from the proximate end of the catheter to the balloon.
  • the outer tubular wall conforms tightly about the external surface of the inner tubular wall except at the distal end where the balloon is formed.
  • the catheter includes at least one lumen, and usually two or more lumens, extending its entire length to provide inflation access at the proximate end.
  • the outer tubular wall conforms about the catheter tube, and at least one lumen is formed in the sheath or flexible reinforcement tube to provide inflation access.
  • a particularly convenient and efficient method is provided for fabricating the vascular dilation catheters of the present invention.
  • An elongate tubular member is first formed by extrusion of a suitable thermoplastic, usually a cross-linked polyolefin or halocarbon (usually fluorocarbon) polymer.
  • a suitable thermoplastic usually a cross-linked polyolefin or halocarbon (usually fluorocarbon) polymer.
  • one or more axial lumens may be formed within the tube wall to extend from a proximate end of the tubular member to the location where the balloon will subsequently be formed.
  • a preselected length of the tubular member usually about half, will then be expanded and rolled back over the remaining length to form the basic involuted structure of the catheter.
  • the balloon can then be formed by further expanding the distal end of the outer tubular wall.
  • the inner tubular wall With a greater thickness in order to enhance the mechanical strength of the catheter.
  • the elongate tubular member is formed from a low strength material, such as a polyolefin, it will usually be desirable to provide a separate flexible reinforcement tube member to enhance the mechanical strength of the catheter.
  • the elongate tubular member then acts as the sheath, as described above.
  • Such a structure is formed by extruding the flexible reinforcement tube over the sheath from one end to the location where the balloon will be formed.
  • the flexible reinforcement tube may include one or more lumens extending from the proximate end to the balloon location, again depending on the particular design being fabricated.
  • the reinforcement tube material covers only a portion of the sheath, and the exposed segment of the sheath is then expanded to an inside diameter greater than the outside diameter of the reinforcement tube.
  • a tri-layer construction comprising an inner sheath layer, a flexible tube layer, and an outer sheath layer is formed, where the inner sheath layer and flexible tube layer together define the inner tubular wall while the outer sheath layer defines the outer tubular wall.
  • the outer sheath layer is then shrunk to a preselected diameter over a first portion of the tube extending from the proximate end to a point spaced inward from the distal end.
  • the portion of the sheath which has not been shrunk defines the dilation balloon, while the shrunken portion either conforms to the catheter tube or defines the annular inflation lumen.
  • a temporary blocking tube is placed over the catheter tube during shrinkage of the sheath.
  • the balloon catheters of the present invention may further include means for heating the inflation medium within the dilation balloon or directly heating the stenosis through the balloon wall in order to perform thermal ablation angioplasty.
  • means for heating the inflation medium within the dilation balloon or directly heating the stenosis through the balloon wall in order to perform thermal ablation angioplasty By employing high temperature thermoplastics, particularly fluorocarbon polymers, as the catheter materials, balloon structures capable of operating at the high temperatures required for ablation therapy may be provided. Such heated balloons are generally free from the disadvantages associated with other thermal ablation techniques, as described above.
  • Figs. 1, 1A, and IB illustrate a first preferred embodiment of a vascular dilation catheter constructed in accordance with the principles of the present invention.
  • Figs. 2-5 illustrate steps of the method for fabricating vascular dilation catheters according to the present invention.
  • Figs. 6, 7, and 8 illustrate alternate preferred embodiments of the vascular dilation catheter of the present invention.
  • Fig. 9 illustrates a vascular catheter constructed in accordance with the principles of the present invention and having an optical waveguide for providing laser energy for heating inflation medium within a dilation balloon to perform thermal ablation angioplasty.
  • Figs. 10A and 10B are alternative cross-sectional views taken along line 10-10 of Fig. 9.
  • Fig. 11 is similar to Fig. 9, but illustrates an electrical resistance heater for the inflation medium.
  • Fig. 12 is a cross-sectional view of a dilation balloon having two separate inflation compartments.
  • the first catheter 10 is of the type including an 165
  • the catheter 10 includes a dilation balloon tip 12 at its distal end and a manifold fitting 14 at its proximate end.
  • the manifold fitting 14 includes a side port 16 for the introduction of inflation medium to the catheter and an axial port 18 for insertion of the catheter 10 over a conventional guidewire (not illustrated) .
  • Additional ports may be provided in the manifold 14 for other connections to the catheter 10, such as a perfusate connection, a bleed line connection permitting the discharge of air from the balloon as it is filled with inflation medium, and the like.
  • Such connections are well known and their incorporation in the catheters of the present invention would be a matter of routine to one skilled in the art.
  • the main body of the vascular dilation catheter 10 comprises a three-layer structure best observed in Fig. 1A.
  • An inner tubular wall 19 includes a flexible reinforcement tube 20 formed over an inner sheath 22, as will be described in more detail hereinafter.
  • An outer tubular wall or sheath 24 circumscribes the flexible tube 20 and is spaced-apart therefrom to define an ' annular lumen 26 which extends the length of the catheter from the balloon tip 12 to the manifold fitting 14.
  • a central lumen 28 also extends the entire length of the catheter 10 from the balloon tip 12 to the fitting 14.
  • the side port 16 of fitting 14 is fluidly connected to the annular lumen 26 to provide for introduction of inflation medium to the balloon 12, while axial port 18 is sealingly connected to the inner lumen 28 to allow for insertion of the catheter 10 over a guidewire (not illustrated) .
  • the balloon tip 12 is defined by the inner sheath 22 extending out of the open end of flexible reinforcement tube 20 and folding back over the exterior surface of said tube so that it becomes outer tubular wall 24 (which is a continuous extension of inner sheath 22) .
  • the diameter of the outer wall or sheath 24 at the distal end of catheter 10 is substantially greater than that over the remaining length of the catheter so that it defines the dilation balloon 12.
  • the internal volume 30 of the dilation balloon 12 forms a continuous volume with the annular lumen 26 which extends through the remaining length of the catheter 10 to the manifold fitting 14.
  • inflation fluid which is introduced through port 16 of fitting 14 will eventually reach the interior volume 30 of the balloon 12.
  • the advantages of the catheter 10 of the present invention arise from the fact that the balloon 12 is an integral portion of the sheaths 22 and 24.
  • the balloon 12 is not sealed to the catheter at all and, in fact, the only sealing required for the catheter may be provided aft the fitting 14.
  • the sheath 22 and 24 is a continuous piece of material entirely free from, seams which are prone to failure and difficult to form. It is a particular advantage that the balloon 12 terminates in a substantially flat or blunt face 13 and is free from the protruding seals which characterized the prior art. Such rigid seals presented a danger of puncturing the wall of the blood vessel being treated, as described above.
  • the catheters 10 will vary depending on the particular use.
  • the catheters 10 will generally have a length in the range from about 40 to 150 centimeters, with lengths from about 40 to 90 centimeters being generally suitable for peripheral arteries and lengths from about 115 to 150 centimeters being generally suitable for coronary arteries.
  • the outside diameter of the catheter (excluding the balloon tip 12) will generally vary from about one-half to two millimeters, with catheters for peripheral arteries 65
  • the balloon tip 12 will have a length typically in the range from about one to twenty centimeters, and a diameter when fully inflated in the range from about one to 30 millimeters, with diameters from one to ten millimeters being suitable for vascular dilation and larger balloons being suitable for dilation of coronary valves.
  • the flexible reinforcement tube 20 will have an outside diameter which is somewhat smaller than the inside diameter of the outer tubular wall or sheath 24.
  • the spacing between the outer wall or sheath 24 and the reinforcement tube 20 (dimension "S" in Fig. 1A) will be in the range from about 0.05 to 0.6 mm.
  • the outside diameter of the inner sheath 22 conforms precisely to the inside diameter of the flexible reinforcement tube 20, while the central lumen has a diameter in the range from about 0.25 to 1.50 mm.
  • the wall thickness of both the inner and outer sheaths 22 and 24 will be in the range from about 0.05 to 0.25 mm, while the wall thickness of the flexible reinforcement tube 20 will be in the range from 0.05 to 0.5 mm.
  • Heat-shri ⁇ kable plastic tubing is provided in a length which is approximately twice that of the desired catheter length.
  • the tubing which subsequently forms both the inner sheath 22 and outer tubular wall or sheath 24, is supported while flexible reinforcement tube 20 is formed thereover, typically by conventional extrusion and/or braiding processes.
  • the flexible reinforcement tube 24 should cover approximately one-half of the length of the sheath material 22/24. That is, the length of the tube 20 will correspond to the desired length of the catheter 10.
  • the flexible reinforcement tube 20 11 may be extruded to the proper length, or may be extruded over a greater length of the sheath 22/24 and then peeled back to the proper length.
  • Suitable heat-shrinkable materials include cross-linked polyolefins, such as polyethylenes, polypropylenes, polyisoprenes; halocarbon polymers, particularly fluorocarbon polymers; and copolymers thereof.
  • polyolefins such as polyethylenes, polypropylenes, polyisoprenes
  • halocarbon polymers particularly fluorocarbon polymers
  • copolymers thereof display strong plastic memory and may be shaped to a desired diameter when heated above their crystalline melting points. If held in shape while cooled, the polyolefin and halocarbon materials will retain their shape indefinitely. On reheating above the crystalline melting point, however, the stressed portion will tend to return to the original shape when cross-linked.
  • the sheath tubing 22/24 should initially be in an unstressed condition such that it will tend to return to its original diameter when heated.
  • Suitable materials for the flexible reinforcement tube 20 include a wide variety of thermoplastics and thermosetting plastics. Unlike certain prior art fabrication methods, the present invention does not require bonding compatibility between the flexible reinforcement tube 20 and the balloon (sheath) material since there will be no bonding in the process. Suitable materials include nylons, polyethylenes, polyolefins, polyvinylchlorides, polyurethanes, halocarbon polymers and the like. The use of polyurethanes is preferred as they are available with a wide variety of mechanical properties which allow the catheter to be tailored to a particular end use. Also suitable are various fiber-reinforced composite materials and braided constructions where a metal braid core is coated with a suitable resin, particularly epoxy and polyurethane resins. The construction of suitable braided catheter tubing is 165
  • the flexible tubing may be reinforced in the region of the balloon 12 in order to prevent collapse of the central lumen 28 during inflation of the balloon.
  • Fig. 3 after flexible reinforcement tube 20 has been formed over approximately one-half the length of the sheath material 22/24, the portion 24 of the sheath material which extends out of the end of tubing 24 is expanded to a diameter corresponding generally to the desired balloon diameter in the final catheter construction.
  • Expansion is accomplished by heating the sheath material and expanding the walls, either by fluid (liquid or gas) pressure or placement over an appropriate mandrel. By cooling the sheath material while in this expanded condition, the shape will be retained indefinitely until the material is again heated.
  • the outer sheath material -24 is next folded back over the flexible tube 20 so that the flexible reinforcement tube 20 is completely enveloped within the sheath material.
  • a spacing mandrel 40 (typically formed from an adhesion-resistant material such as polytetrafluoro- ethylene available under the tradename Teflon®) is next inserted over the flexible tube 20 extending at least until the point where it is desired to form the dilation balloon 12.
  • the sheath material 24 is next heated along the length of the catheter, with the exception of the length where it is desired to form the balloon 12. By heating above the crystalline melting point for the material employed, the sheath material 24 13 will tend to shrink back to its original diameter.
  • the spacing mandrel 40 prevents full shrinkage back and instead terminates the shrinkage at the desired inside diameter for the outer sheath wall 24. Once the desired diameter is reached, the material may again be cooled and the mandrel 40 removed. The final product, as illustrated in Fig. 5, is thus obtained.
  • the catheters 10 of the present invention may be used in conventional vascular angioplastic techniques, such as those described in U.S. Patent 4,323,071, the disclosure of which is incorporated herein by reference. Briefly, the catheter 10 will be located within the patient's vascular system by inserting the central lumen 28 over a guidewire (not illustrated) . Once the dilation balloon 12 of the catheter 10 is properly located in a region of stenosis, the balloon 12 is inflated by introducing an inflation medium through port 16 of fitting 14. The inflation medium travels through the annular lumen 26 eventually reaching the internal volume 30 of the balloon 12. The balloon 12 is expanded one or more times for short periods of time until it appears that the stenosed region has been adequately enlarged.
  • a sheath 50 is formed from the same materials and by the same methods as described above for sheath 22/24.
  • a flexible reinforcement tube 52 is also formed from the same materials as described above for flexible reinforcement tube 20, and the tube will be extruded over the sheath and the sheath folded back in the same general manner as for the first embodiment.
  • Flexible reinforcement tube 52 will include at least one, and usually a plurality of axial lumens 54 extending the entire length of the tube.
  • the lumens 54 terminate in ports 58 which open into the interior of the balloon 56.
  • one or more of the lumens can be used to supply inflation medium,while one or more of the remaining lumens are used to vent the balloon.
  • a sheath 70 is formed from the same materials as described above for sheath 22/24.
  • the method of formation of sheath 70 is also similar, except that a portion of the sheath length will have a somewhat greater wall thickness and one or more axial lumens 72 formed therein.
  • the lumens 72 terminate in ports 74 which open into the interior of balloon 76.
  • the balloon 76 is formed after the sheath 70 is folded back over flexible catheter tube 78 which is extruded over sheath 70 in the same manner as described for flexible reinforcement tube 20 above.
  • the sheath 70 is then heat shrunk to conform tightly to the tube 78 to seal the balloon 76.
  • Inflation access is provided by lumen(s) 74.
  • the dilation balloons 56 and 76 are sealed by heat shrinking the sheaths 50 and 70 to the flexible catheter tubes 52 and 78.
  • the sheaths 50 and 70 will extend the entire length of the catheter providing an excellent seal with virtually no likelihood of failure.
  • the seal need not extend the entire length of the catheter and it is necessary only that a sufficient seal length be provided to assure that there will be no leakage of the inflation media.
  • a sheath 80 is formed from the same materials as described above for sheath 22/24.
  • Sheath 80 includes at least two axial lumens 82 and 84 extending its entire length.
  • the lumens 82 and 84 will be crescent-shaped and occupy a substantial portion of the cross-sectional area of the sheath, typically about 50% of the area, or more.
  • a flexible catheter tube 86 is formed over a portion of the length of sheath 80, and the remaining length of sheath 80 folded back over the tube 86.
  • the sheath 80 is then heat shrunk, except for the distal end 88 which remains expanded to define the dilation balloon.
  • the interior of the balloon is formed by the expanded lumens 82 and 84, and inflation medium can be supplied through the remaining lengths of the lumens.
  • the central lumen 28 may be shrunk onto a guidewire to reduce the diameter.
  • the catheter would then, of course, be limited to fixed or semi-fixed guidewire applications. Alternatively, it would be possible to attach a coiled spring to the flexible tube to provide a self-guiding catheter.
  • the catheter constructions described have all included an inner tubular wall including both a sheath layer and a reinforcement tube layer.
  • Such two-layer constructions for the inner tubular wall are not necessary and it is often desirable to fabricate catheters which include only a single layer of thermoplastic material which is folded back over itself to form the desired involuted structure of the present invention.
  • Such single-layer constructions are particularly suitable when employing thermoplastics having a relatively high mechanical strength, such as halocarbon polymers, and the like.
  • Figs. 9, 10A, and 10B a catheter 100 which employs a single-layer construction will be described. 16
  • the catheter 100 is formed from a single tube of extruded thermoplastic material generally as described above, but without the formation of a flexible reinforcement tube layer thereover.
  • the extruded thermoplastic tube may have a greater wall thickness over the segment which eventually forms the inner tubular wall in order to enhance its mechanical strength. The thickness of the portion which eventually forms the outer tubular wall may be reduced by axially stretching that segment.
  • the catheter 100 includes inner tubular wall
  • dilation balloon 106 being formed by expansion of the distal end of the outer tubular wall.
  • An annular lumen 107 will usually be left in the region between walls 104 and 106 extending from the balloon back to the proximate end (not shown) , although separate inflation lumens may be provided within the inner tubular wall or outer tubular wall, as described above.
  • the structure of the present invention is particularly advantageous in that it allows construction from high temperature polymers, particularly halocarbon polymers, more particularly fluorocarb ⁇ n polymers which are not amenable to normal sealing techniques.
  • high temperature polymers particularly halocarbon polymers, more particularly fluorocarb ⁇ n polymers which are not amenable to normal sealing techniques.
  • thermoplastic construction material is substantially unrestricted.
  • Fluorocarbon polymers such as polytetrafluoroethylene, fluorinated ethylene propylene polymers, chlorotrifluoroethylene polymers, polyvinylidene fluoride, and hexafluoropropylene polymers, are particularly suitable for the construction of thermal ablation balloon catheters, as 17 described below, which require high temperature operation.
  • An optical waveguide 110 is provided in the catheter 100 of Fig. 9.
  • the optical waveguide 110 allows the transmission of laser energy to the inflation medium within the balloon 106, allowing heating thereof.
  • means for dispersing the thermal energy within the balloon volume, or multiple waveguides may be provided to enhance the heating uniformity.
  • an opaque inflation medium will be employed and the wavelength of the laser energy will be selected to enhance the energy absorption and heating of the inflation medium. By thus heating the inflation medium, convective heating of the stenotic material may be achieved.
  • the wavelength of the laser energy may be selected to enhance transmission through both the inflation medium and the balloon wall, allowing direct radiative heating and ablation of the material obstructing the blood vessle.
  • Particularly suitable laser types for both conductive and radiative heating are set forth in the following list. Laser Type Wave Length Effect
  • Carbon Dioxide 10,600 nm Absorbed by inflation medium including water, saline, with or without contrast agents.
  • Argon 488-514 n Absorbed by pigmented tissues, hemoglobin, yoglobin, and colored inflation medium, particularly red-orange.
  • Tunable dye 330-1250 n Can selectively duplicate effect of argon, ex ⁇ ime, and Nd-YAG lasers.
  • a thinned region 120 in the outer tubular wall 104 defining the inflation balloon 106 will enhance the heat transfer across that portion of the wall, allowing the thermal treatment to be more specifically directed at (localized) particular circumferential regions of the stenosis.
  • an alternative catheter embodiment 130 is illustrated.
  • the catheter 130 is substantially similar to catheter 100, except that an electrical resistance heating element 132, typically a wire coiled around the inner tubular wall 102, is provided in place of the optical waveguide 110. In this way, electrical heating of the inflation medium within the balloon 106 " may be utilized.
  • Wire connections 134 may be provided from the heating element 32 to the proximate end (not illustrated) of the catheter for connection to an appropriate power supply.
  • Thermocouples or thermisters (not illustrated) within the balloon 106 may be provided to monitor and control the temperature of the inflation medium.
  • a catheter embodiment 140 having multiple compartments within the inflation balloon is illustrated.
  • Such a multiple compartment construction may be provided by involution of a multi-lumen thermoplastic tube, by the techniques described above. As illustrated in Fig. 12, a dual-lumen tube was utilized, resulting in compartments 19
  • Such multiple compartment constructions are useful as they allow selective heating of one or more of the compartments, while leaving the other compartments substantially unheated. Such localized heating is useful when it is desired to direct the heat at particular circumferential segments of the stenosis.
  • the balloon catheters of the present invention will be inserted into the patient's vascular system by conventional techniques, typically employing guidewires 108. Once the catheter balloons are located within the region of stenosis, the balloons will be dilated, typically at a pressure in the range from about 10 to 200 psi, more typically in the range from about 25 to 120 psi.
  • the inflation medium within the balloon will be heated, typically to a temperature in the range from about 120 to 200*C, more typically in the range from about 130 to 180*C, for a time sufficient to cause dehydration, cellular shrinkage, and ultimately vaporization or ablation of the stenotic material, usually in the range from about 5 to 60 seconds more usually being at least about 10 seconds at lower temperatures near 120*C and at least about 5 seconds at-higher e peratures near 180*C.
  • the continuous nature of the sheath defining the inflation balloon is critical in allowing operation at such elevated temperatures.
  • Thermal ablation angioplasty utilizing heated balloon catheters is an improvement over both conventional balloon angioplasty and thermal ablation techniques employing direct laser energy and heated metallic caps. Balloon thermal ablation does not have a significant risk of restenosis and abrupt closure, as suffered by conventional balloon angioplasty. Moreover, the use of the heated balloon does not result in a substantial risk of puncture as 165

Abstract

An improved vascular dilation cathether (10) comprises an involuted tubular structure including outer (24) and inner (22) tubular walls which extend the entire length of the catheter (10). The outer tubular wall (24) is enlarged at a distal end of the catheter (10) to form a dilation balloon (12), and extends back the remaining length of the flexible tube (20), at a reduced diameter to define an annular lumen (26) which is used to inflate the balloon (12). Alternatively, the outer tubular wall (24) may conform to the exterior of the inner tubular wall (22) and separate axial lumens (58) may be provided for inflation. By providing means for heating inflation medium within the balloon, the catheter may be utilized for performing thermal ablation therapy.

Description

IMPROVED VASCULAR DILATION CATHETER CONSTRUCTION BACKGROUND OF THE INVENTION The present application is a continuation-in-part of application serial number 131,775 filed on December 11, 1987, the entire disclosure of which is incorporated herein by reference.
1. Field of the Invention The present invention relates generally to the construction of dilation catheters for angioplastic treatment of obstructed blood vessels, and more particularly to an improved catheter construction wherein a sheath envelopes a flexible catheter tube to define both a dilation balloon at a distal end of the tube and an annular lumen connecting the balloon to a proximate end of the tube.
Balloon angioplasty was first described by Andreas Gruntzig in 1977. Dr. Gruntzig employed a balloon-tipped flexible catheter to percutaneously dilate a region of stenosis within the coronary artery of a patient with atherosclerotic coronary artery disease. Since the original work, the use of percutaneous balloon angioplasty has become widespread, with treatment of occluded peripheral blood vessels as well as coronary arteries.
A common type of dilation catheter consists of a pair of coaxial tubes which are sealed together at a distal end. The outer tube is expanded to form a balloon near a distal end of the catheter and a narrow annular lumen extends from the balloon to a proximate end. A fitting is secured to the proximate end, allowing for the infusion of an inflation medium through the annular lumen to the balloon. The catheter may be inserted over a guidewire to the desired location within a blood vessel, and inflated to dilate a stenosed region by now well known techniques. The dilation catheter construction just described suffers from several drawbacks. In particular, the need to seal the outer tube to the inner catheter tube limits the choice of materials 5 available for both tubes. For example, cross-linked polyolefins and halocarbon polymers, which are desirable as the material for the outer tube which defines the balloon, are difficult to bond to other materials suitable for the inner tube. Thus, most 0 coaxial balloon catheters either avoid the use of such materials, compromise on the material used for the inner tube, or provide elaborate means for sealing the distal end. Second, even when compatible materials are chosen, the seam at the bonded end will be subject to *5 failure when the catheter is use. Inflation pressures on the order of 80 to 260 psi are common, and bursting of the catheter could result in serious complications. Third, coaxial catheter constructions have typically included a rigid segment having a length on the order 0 of l cm at the distal tip of the catheter. Such a 1 rigid tip can, when the adjacent balloon is inflated, be pressed against the vessel wall. During the treatment of particularly tortuous vessels and/or with very high dilation pressures, the rigid tip can *-' sometimes puncture the vessel wall. Finally, the construction methods employed in fabricating conventional dilation catheters are problematic and time consuming, increasing both the cost of production and the difficulty of meeting product specifications. 0 As an alternative to balloon angioplasty, various approaches have been proposed for the thermal ablation of vascular obstructions, including the use of direct laser radiation and heated contact elements. Although such techniques would be free from certain 5 drawbacks of conventional balloon angioplasty, including restenosis and abrupt reclosure of the blood vessel, they suffer from their own disadvantages. Specifically, direct laser radiation can accidentally pierce the blood vessel wall, and it is often difficult to contact a heated element against the desired region of stenosis, particularly when the stenosis is non-uniformly distributed around the blood vessel.
Heating the inflation medium within balloons has been proposed as a method for remolding dissections which occur during conventional angioplasty, causing restenosis and abrupt reclosure. Heating for such remolding generally is carried out at lower temperatures than for ablation.
It would therefore be desirable to provide improved dilation catheters and methods for fabricating dilation catheters which do not require bonding between an inner tube and an outer tube, as described above, and which are free from rigid sealing segments at their distal ends. Moreover, it would be desirable that such methods allow for a wider selection of catheter materials and simplify the fabrication process to both reduce the cost of the process and provide for improved product quality. In particular, it would be desirable if such dilation catheters could be used in methods for the thermal ablation of vascular obstructions where the inflation medium within the balloon is heated to relatively high temperatures.
2. Description of the Background Art
The basic technique of balloon angioplasty is taught in U.S. Patent No. 4,195,637. U.S. Patent No. 4,323,071 and PCT Patent WO 87/00442 each describe the construction of coaxial balloon-tipped dilation catheters of the type described above. The use of direct laser energy for ablating stenosis is described in U.S. Patent Nos. 4,445,892 and 4,448,188, and Sanborn et al. (1985) J. Am. Col. Cardiol. 5:934-938. Ablation of stenosis using a laser-heated metallic cap is described in Welch et al. (1987) Circulation 76:1353-1363, Sanborn et al. (1985) supra., and Lee et 5165
al. (1987) Am. Heart J. 113:1507-1508 and 114:1524-1526. The use of direct laser energy for the fusion of tissue dissected during balloon angioplasty is suggested in Spears (1987) Am. J. Cardiol. 61B-64B; Spears (1986) Cardiovasc. Intervent. Radiol. 9:303-312; and Hiehle, Jr., et al. (1985) Am. J. Cardiol. 56:953-957. U.S. Patent No. 4,470,407 describes an endoscope which employs a laser-illuminated balloon. U.S. Patent No. 4,754,752 describes a balloon catheter having a metal block heated by laser energy for convectively heating inflation medium within the balloon.
SUMMARY OF THE INVENTION According to the present invention, improved vascular dilation catheters are constructed by a novel fabrication method. Specifically, the vascular dilation catheters comprise a continuous, involuted structure including outer and inner tubular walls which are joined without seams at a distal end thereof. The outer tubular wall is expanded near the distal end to define the dilation balloon. Optionally, the inner tubular wall further includes a separate flexible reinforcement tube with a sheath extending over both the internal and external surfaces of the reinforcement tube to complete the involuted structure. The sheath is folded over a distal end of the flexible reinforcement tube and is expanded at or near the distal end to define a dilation balloon.
The entire dilation balloon is thus _ completely free from seams and seals which are subject to failure and limit the choice of usable materials. In particular, there is no rigid sealing segment at the distal end of the catheter as has been previously required in most other balloon catheter constructions. Moreover, the fabrication method is particularly convenient, inexpensive, and provides very high product quality. In a first preferred embodiment, the outer tubular wall is spaced-apart from the external surface of the inner tubular wall to define an annular lumen along the entire length from the balloon to the proximate end of the catheter. The annular lumen provides an inlet conduit for inflation medium from the proximate end of the catheter to the balloon.
In a second preferred embodiment, the outer tubular wall conforms tightly about the external surface of the inner tubular wall except at the distal end where the balloon is formed. The catheter includes at least one lumen, and usually two or more lumens, extending its entire length to provide inflation access at the proximate end. In a third preferred embodiment, the outer tubular wall conforms about the catheter tube, and at least one lumen is formed in the sheath or flexible reinforcement tube to provide inflation access.
A particularly convenient and efficient method is provided for fabricating the vascular dilation catheters of the present invention. An elongate tubular member is first formed by extrusion of a suitable thermoplastic, usually a cross-linked polyolefin or halocarbon (usually fluorocarbon) polymer. Depending on the particular design, one or more axial lumens may be formed within the tube wall to extend from a proximate end of the tubular member to the location where the balloon will subsequently be formed. A preselected length of the tubular member, usually about half, will then be expanded and rolled back over the remaining length to form the basic involuted structure of the catheter. The balloon can then be formed by further expanding the distal end of the outer tubular wall. Frequently, it will be desirable to provide the inner tubular wall with a greater thickness in order to enhance the mechanical strength of the catheter. When the elongate tubular member is formed from a low strength material, such as a polyolefin, it will usually be desirable to provide a separate flexible reinforcement tube member to enhance the mechanical strength of the catheter. The elongate tubular member then acts as the sheath, as described above. Such a structure is formed by extruding the flexible reinforcement tube over the sheath from one end to the location where the balloon will be formed. The flexible reinforcement tube may include one or more lumens extending from the proximate end to the balloon location, again depending on the particular design being fabricated. The reinforcement tube material covers only a portion of the sheath, and the exposed segment of the sheath is then expanded to an inside diameter greater than the outside diameter of the reinforcement tube. By folding the sheath back over the exterior of the flexible reinforcement tube, a tri-layer construction comprising an inner sheath layer, a flexible tube layer, and an outer sheath layer is formed, where the inner sheath layer and flexible tube layer together define the inner tubular wall while the outer sheath layer defines the outer tubular wall. The outer sheath layer is then shrunk to a preselected diameter over a first portion of the tube extending from the proximate end to a point spaced inward from the distal end. The portion of the sheath which has not been shrunk defines the dilation balloon, while the shrunken portion either conforms to the catheter tube or defines the annular inflation lumen. To form the annular lumen, a temporary blocking tube is placed over the catheter tube during shrinkage of the sheath.
The balloon catheters of the present invention may further include means for heating the inflation medium within the dilation balloon or directly heating the stenosis through the balloon wall in order to perform thermal ablation angioplasty. By employing high temperature thermoplastics, particularly fluorocarbon polymers, as the catheter materials, balloon structures capable of operating at the high temperatures required for ablation therapy may be provided. Such heated balloons are generally free from the disadvantages associated with other thermal ablation techniques, as described above.
BRIEF DESCRIPTION OF THE DRAWINGS Figs. 1, 1A, and IB illustrate a first preferred embodiment of a vascular dilation catheter constructed in accordance with the principles of the present invention.
Figs. 2-5 illustrate steps of the method for fabricating vascular dilation catheters according to the present invention.
Figs. 6, 7, and 8 illustrate alternate preferred embodiments of the vascular dilation catheter of the present invention.
Fig. 9 illustrates a vascular catheter constructed in accordance with the principles of the present invention and having an optical waveguide for providing laser energy for heating inflation medium within a dilation balloon to perform thermal ablation angioplasty. Figs. 10A and 10B are alternative cross-sectional views taken along line 10-10 of Fig. 9. Fig. 11 is similar to Fig. 9, but illustrates an electrical resistance heater for the inflation medium.
Fig. 12 is a cross-sectional view of a dilation balloon having two separate inflation compartments.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Referring now to Fig. 1, a first vascular dilation catheter 10 constructed in accordance with the principles of the present invention will be described. The first catheter 10 is of the type including an 165
8 annular lumen providing inflation access to a dilation balloon. The catheter 10 includes a dilation balloon tip 12 at its distal end and a manifold fitting 14 at its proximate end. The manifold fitting 14 includes a side port 16 for the introduction of inflation medium to the catheter and an axial port 18 for insertion of the catheter 10 over a conventional guidewire (not illustrated) . Additional ports (not illustrated) may be provided in the manifold 14 for other connections to the catheter 10, such as a perfusate connection, a bleed line connection permitting the discharge of air from the balloon as it is filled with inflation medium, and the like. Such connections are well known and their incorporation in the catheters of the present invention would be a matter of routine to one skilled in the art.
The main body of the vascular dilation catheter 10 comprises a three-layer structure best observed in Fig. 1A. An inner tubular wall 19 includes a flexible reinforcement tube 20 formed over an inner sheath 22, as will be described in more detail hereinafter. An outer tubular wall or sheath 24 circumscribes the flexible tube 20 and is spaced-apart therefrom to define an'annular lumen 26 which extends the length of the catheter from the balloon tip 12 to the manifold fitting 14. A central lumen 28 also extends the entire length of the catheter 10 from the balloon tip 12 to the fitting 14. The side port 16 of fitting 14 is fluidly connected to the annular lumen 26 to provide for introduction of inflation medium to the balloon 12, while axial port 18 is sealingly connected to the inner lumen 28 to allow for insertion of the catheter 10 over a guidewire (not illustrated) .
As best observed in Fig. IB, the balloon tip 12 is defined by the inner sheath 22 extending out of the open end of flexible reinforcement tube 20 and folding back over the exterior surface of said tube so that it becomes outer tubular wall 24 (which is a continuous extension of inner sheath 22) . The diameter of the outer wall or sheath 24 at the distal end of catheter 10 is substantially greater than that over the remaining length of the catheter so that it defines the dilation balloon 12. The internal volume 30 of the dilation balloon 12 forms a continuous volume with the annular lumen 26 which extends through the remaining length of the catheter 10 to the manifold fitting 14. Thus, inflation fluid which is introduced through port 16 of fitting 14 will eventually reach the interior volume 30 of the balloon 12.
The advantages of the catheter 10 of the present invention arise from the fact that the balloon 12 is an integral portion of the sheaths 22 and 24.
Thus, the balloon 12 is not sealed to the catheter at all and, in fact, the only sealing required for the catheter may be provided aft the fitting 14. Moreover, the sheath 22 and 24 is a continuous piece of material entirely free from, seams which are prone to failure and difficult to form. It is a particular advantage that the balloon 12 terminates in a substantially flat or blunt face 13 and is free from the protruding seals which characterized the prior art. Such rigid seals presented a danger of puncturing the wall of the blood vessel being treated, as described above.
The dimensions of the vascular dilation catheter 10 will vary depending on the particular use. For peripheral arteries, the catheters 10 will generally have a length in the range from about 40 to 150 centimeters, with lengths from about 40 to 90 centimeters being generally suitable for peripheral arteries and lengths from about 115 to 150 centimeters being generally suitable for coronary arteries. The outside diameter of the catheter (excluding the balloon tip 12) will generally vary from about one-half to two millimeters, with catheters for peripheral arteries 65
10 generally being larger. The balloon tip 12 will have a length typically in the range from about one to twenty centimeters, and a diameter when fully inflated in the range from about one to 30 millimeters, with diameters from one to ten millimeters being suitable for vascular dilation and larger balloons being suitable for dilation of coronary valves.
The flexible reinforcement tube 20 will have an outside diameter which is somewhat smaller than the inside diameter of the outer tubular wall or sheath 24. Typically, the spacing between the outer wall or sheath 24 and the reinforcement tube 20 (dimension "S" in Fig. 1A) will be in the range from about 0.05 to 0.6 mm. The outside diameter of the inner sheath 22 conforms precisely to the inside diameter of the flexible reinforcement tube 20, while the central lumen has a diameter in the range from about 0.25 to 1.50 mm. Typically, the wall thickness of both the inner and outer sheaths 22 and 24 will be in the range from about 0.05 to 0.25 mm, while the wall thickness of the flexible reinforcement tube 20 will be in the range from 0.05 to 0.5 mm.
Referring now to Figs. 2-5, a method for fabricating vascular dilation catheters 10 according to the principles of the present invention will be described. Heat-shriήkable plastic tubing is provided in a length which is approximately twice that of the desired catheter length. The tubing, which subsequently forms both the inner sheath 22 and outer tubular wall or sheath 24, is supported while flexible reinforcement tube 20 is formed thereover, typically by conventional extrusion and/or braiding processes. The flexible reinforcement tube 24 should cover approximately one-half of the length of the sheath material 22/24. That is, the length of the tube 20 will correspond to the desired length of the catheter 10. To that end, the flexible reinforcement tube 20 11 may be extruded to the proper length, or may be extruded over a greater length of the sheath 22/24 and then peeled back to the proper length.
Suitable heat-shrinkable materials include cross-linked polyolefins, such as polyethylenes, polypropylenes, polyisoprenes; halocarbon polymers, particularly fluorocarbon polymers; and copolymers thereof. Such materials display strong plastic memory and may be shaped to a desired diameter when heated above their crystalline melting points. If held in shape while cooled, the polyolefin and halocarbon materials will retain their shape indefinitely. On reheating above the crystalline melting point, however, the stressed portion will tend to return to the original shape when cross-linked. For use in the present invention, the sheath tubing 22/24 should initially be in an unstressed condition such that it will tend to return to its original diameter when heated. Suitable materials for the flexible reinforcement tube 20 include a wide variety of thermoplastics and thermosetting plastics. Unlike certain prior art fabrication methods, the present invention does not require bonding compatibility between the flexible reinforcement tube 20 and the balloon (sheath) material since there will be no bonding in the process. Suitable materials include nylons, polyethylenes, polyolefins, polyvinylchlorides, polyurethanes, halocarbon polymers and the like. The use of polyurethanes is preferred as they are available with a wide variety of mechanical properties which allow the catheter to be tailored to a particular end use. Also suitable are various fiber-reinforced composite materials and braided constructions where a metal braid core is coated with a suitable resin, particularly epoxy and polyurethane resins. The construction of suitable braided catheter tubing is 165
12 described in U.S. patent application serial no. 072,439, filed on June 9, 1987, for Guiding Catheter, the disclosure of which is incorporated herein by reference. Finally, multiple layer constructions including two or more of the materials just described may also find use. In a particular application, the flexible tubing may be reinforced in the region of the balloon 12 in order to prevent collapse of the central lumen 28 during inflation of the balloon. Referring now in particular to Fig. 3, after flexible reinforcement tube 20 has been formed over approximately one-half the length of the sheath material 22/24, the portion 24 of the sheath material which extends out of the end of tubing 24 is expanded to a diameter corresponding generally to the desired balloon diameter in the final catheter construction. Expansion is accomplished by heating the sheath material and expanding the walls, either by fluid (liquid or gas) pressure or placement over an appropriate mandrel. By cooling the sheath material while in this expanded condition, the shape will be retained indefinitely until the material is again heated.
Referring now to Fig. 4, the outer sheath material -24 is next folded back over the flexible tube 20 so that the flexible reinforcement tube 20 is completely enveloped within the sheath material. A spacing mandrel 40 (typically formed from an adhesion-resistant material such as polytetrafluoro- ethylene available under the tradename Teflon®) is next inserted over the flexible tube 20 extending at least until the point where it is desired to form the dilation balloon 12. The sheath material 24 is next heated along the length of the catheter, with the exception of the length where it is desired to form the balloon 12. By heating above the crystalline melting point for the material employed, the sheath material 24 13 will tend to shrink back to its original diameter. The spacing mandrel 40, however, prevents full shrinkage back and instead terminates the shrinkage at the desired inside diameter for the outer sheath wall 24. Once the desired diameter is reached, the material may again be cooled and the mandrel 40 removed. The final product, as illustrated in Fig. 5, is thus obtained.
After connection to a manifold fitting 14, as described previously, the catheters 10 of the present invention may be used in conventional vascular angioplastic techniques, such as those described in U.S. Patent 4,323,071, the disclosure of which is incorporated herein by reference. Briefly, the catheter 10 will be located within the patient's vascular system by inserting the central lumen 28 over a guidewire (not illustrated) . Once the dilation balloon 12 of the catheter 10 is properly located in a region of stenosis, the balloon 12 is inflated by introducing an inflation medium through port 16 of fitting 14. The inflation medium travels through the annular lumen 26 eventually reaching the internal volume 30 of the balloon 12. The balloon 12 is expanded one or more times for short periods of time until it appears that the stenosed region has been adequately enlarged.
Referring now to Fig. 6, a first alternative construction of the catheter of the present invention will be described. A sheath 50 is formed from the same materials and by the same methods as described above for sheath 22/24. A flexible reinforcement tube 52 is also formed from the same materials as described above for flexible reinforcement tube 20, and the tube will be extruded over the sheath and the sheath folded back in the same general manner as for the first embodiment. Flexible reinforcement tube 52, however, will include at least one, and usually a plurality of axial lumens 54 extending the entire length of the tube. The sheath 65
14
50 is shrunken to conform tightly to the flexible tube 52 along the entire length of the tube, except at the , distal end where dilation balloon 56 is located. The lumens 54 terminate in ports 58 which open into the interior of the balloon 56. When multiple lumens 54 are employed, one or more of the lumens can be used to supply inflation medium,while one or more of the remaining lumens are used to vent the balloon.
Referring now to Fig. 7, a second alternative construction of the catheter of the present invention will be described. A sheath 70 is formed from the same materials as described above for sheath 22/24. The method of formation of sheath 70 is also similar, except that a portion of the sheath length will have a somewhat greater wall thickness and one or more axial lumens 72 formed therein. The lumens 72 terminate in ports 74 which open into the interior of balloon 76. The balloon 76 is formed after the sheath 70 is folded back over flexible catheter tube 78 which is extruded over sheath 70 in the same manner as described for flexible reinforcement tube 20 above. The sheath 70 is then heat shrunk to conform tightly to the tube 78 to seal the balloon 76. Inflation access is provided by lumen(s) 74. In the embodiments of both Figs. 6 and 7, the dilation balloons 56 and 76, respectively, are sealed by heat shrinking the sheaths 50 and 70 to the flexible catheter tubes 52 and 78. Normally, the sheaths 50 and 70 will extend the entire length of the catheter providing an excellent seal with virtually no likelihood of failure. The seal, of course, need not extend the entire length of the catheter and it is necessary only that a sufficient seal length be provided to assure that there will be no leakage of the inflation media.
Referring now to Fig. 8, a third alternative construction of the catheter of the present invention 15 is illustrated. A sheath 80 is formed from the same materials as described above for sheath 22/24. Sheath 80, however, includes at least two axial lumens 82 and 84 extending its entire length. Usually, the lumens 82 and 84 will be crescent-shaped and occupy a substantial portion of the cross-sectional area of the sheath, typically about 50% of the area, or more. A flexible catheter tube 86 is formed over a portion of the length of sheath 80, and the remaining length of sheath 80 folded back over the tube 86. The sheath 80 is then heat shrunk, except for the distal end 88 which remains expanded to define the dilation balloon. The interior of the balloon is formed by the expanded lumens 82 and 84, and inflation medium can be supplied through the remaining lengths of the lumens.
In another modification of the catheter 10, the central lumen 28 may be shrunk onto a guidewire to reduce the diameter. The catheter would then, of course, be limited to fixed or semi-fixed guidewire applications. Alternatively, it would be possible to attach a coiled spring to the flexible tube to provide a self-guiding catheter.
To this point, the catheter constructions described have all included an inner tubular wall including both a sheath layer and a reinforcement tube layer. Such two-layer constructions for the inner tubular wall, however, are not necessary and it is often desirable to fabricate catheters which include only a single layer of thermoplastic material which is folded back over itself to form the desired involuted structure of the present invention. Such single-layer constructions are particularly suitable when employing thermoplastics having a relatively high mechanical strength, such as halocarbon polymers, and the like. Referring now to Figs. 9, 10A, and 10B, a catheter 100 which employs a single-layer construction will be described. 16
The catheter 100 is formed from a single tube of extruded thermoplastic material generally as described above, but without the formation of a flexible reinforcement tube layer thereover. Optionally, the extruded thermoplastic tube may have a greater wall thickness over the segment which eventually forms the inner tubular wall in order to enhance its mechanical strength. The thickness of the portion which eventually forms the outer tubular wall may be reduced by axially stretching that segment.
Such wall thickness reduction is particularly desirable for the region which will eventually form the inflation balloon where a greater degree of flexibility or slackness is required. The catheter 100 includes inner tubular wall
102 and outer tubular wall 104, with dilation balloon 106 being formed by expansion of the distal end of the outer tubular wall. An annular lumen 107 will usually be left in the region between walls 104 and 106 extending from the balloon back to the proximate end (not shown) , although separate inflation lumens may be provided within the inner tubular wall or outer tubular wall, as described above.
The structure of the present invention is particularly advantageous in that it allows construction from high temperature polymers, particularly halocarbon polymers, more particularly fluorocarbσn polymers which are not amenable to normal sealing techniques. As the structure of the present invention does not require sealing, the choice of thermoplastic construction material is substantially unrestricted. Fluorocarbon polymers, such as polytetrafluoroethylene, fluorinated ethylene propylene polymers, chlorotrifluoroethylene polymers, polyvinylidene fluoride, and hexafluoropropylene polymers, are particularly suitable for the construction of thermal ablation balloon catheters, as 17 described below, which require high temperature operation.
An optical waveguide 110 is provided in the catheter 100 of Fig. 9. The optical waveguide 110 allows the transmission of laser energy to the inflation medium within the balloon 106, allowing heating thereof. Optionally, means for dispersing the thermal energy within the balloon volume, or multiple waveguides, may be provided to enhance the heating uniformity. Usually, an opaque inflation medium will be employed and the wavelength of the laser energy will be selected to enhance the energy absorption and heating of the inflation medium. By thus heating the inflation medium, convective heating of the stenotic material may be achieved. Alternatively, the wavelength of the laser energy may be selected to enhance transmission through both the inflation medium and the balloon wall, allowing direct radiative heating and ablation of the material obstructing the blood vessle. Particularly suitable laser types for both conductive and radiative heating are set forth in the following list. Laser Type Wave Length Effect
Carbon Dioxide 10,600 nm Absorbed by inflation medium including water, saline, with or without contrast agents.
Argon 488-514 n Absorbed by pigmented tissues, hemoglobin, yoglobin, and colored inflation medium, particularly red-orange.
Nd-YAG 1060 nm Absorbed by
(neodymium- vessel wall and yHriu aluminum proteins. garnet) 165
18
Excimer 194-309 nm Very high absorption by proteins and lipids in atherosclerotic tissue, with minimum penetration depth.
Tunable dye 330-1250 n Can selectively duplicate effect of argon, exσime, and Nd-YAG lasers.
Referring in particular to Fig. 10B, it will sometimes be desirable to provide a thinned region 120 in the outer tubular wall 104 defining the inflation balloon 106. Such reduced wall thickness will enhance the heat transfer across that portion of the wall, allowing the thermal treatment to be more specifically directed at (localized) particular circumferential regions of the stenosis.
Referring now to Fig. 11, an alternative catheter embodiment 130 is illustrated. The catheter 130 is substantially similar to catheter 100, except that an electrical resistance heating element 132, typically a wire coiled around the inner tubular wall 102, is provided in place of the optical waveguide 110. In this way, electrical heating of the inflation medium within the balloon 106"may be utilized. Wire connections 134 may be provided from the heating element 32 to the proximate end (not illustrated) of the catheter for connection to an appropriate power supply. Thermocouples or thermisters (not illustrated) within the balloon 106 may be provided to monitor and control the temperature of the inflation medium.
Referring now to Fig. 12, a catheter embodiment 140 having multiple compartments within the inflation balloon is illustrated. Such a multiple compartment construction may be provided by involution of a multi-lumen thermoplastic tube, by the techniques described above. As illustrated in Fig. 12, a dual-lumen tube was utilized, resulting in compartments 19
142 and 144 which are separated by walls 146 and 148. Such multiple compartment constructions are useful as they allow selective heating of one or more of the compartments, while leaving the other compartments substantially unheated. Such localized heating is useful when it is desired to direct the heat at particular circumferential segments of the stenosis.
For performing thermal ablation angioplasty, the balloon catheters of the present invention will be inserted into the patient's vascular system by conventional techniques, typically employing guidewires 108. Once the catheter balloons are located within the region of stenosis, the balloons will be dilated, typically at a pressure in the range from about 10 to 200 psi, more typically in the range from about 25 to 120 psi. After inflation, the inflation medium within the balloon will be heated, typically to a temperature in the range from about 120 to 200*C, more typically in the range from about 130 to 180*C, for a time sufficient to cause dehydration, cellular shrinkage, and ultimately vaporization or ablation of the stenotic material, usually in the range from about 5 to 60 seconds more usually being at least about 10 seconds at lower temperatures near 120*C and at least about 5 seconds at-higher e peratures near 180*C. The continuous nature of the sheath defining the inflation balloon is critical in allowing operation at such elevated temperatures. •
Thermal ablation angioplasty utilizing heated balloon catheters, as described herein, is an improvement over both conventional balloon angioplasty and thermal ablation techniques employing direct laser energy and heated metallic caps. Balloon thermal ablation does not have a significant risk of restenosis and abrupt closure, as suffered by conventional balloon angioplasty. Moreover, the use of the heated balloon does not result in a substantial risk of puncture as 165
20 with direct laser ablation and provides a much more efficient degree of heat transfer than with heated metal cap catheters.
Although the foregoing invention has been . described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

Claims

21 WHAT IS CLAIMED IS:
1. A vascular dilation catheter comprising: an inner and an outer tubular wall formed as
5 a continuous, involuted structure having proximate and distal ends; a dilation balloon defined by an expanded portion of the outer tubular wall at the distal end of the continuous, involuted structure; and 1° means for directing an inflation medium from the proximate end of the structure to the dilation balloon.
2. A vascular dilation catheter as in claim -5 l, wherein the means for directing an inflation medium includes a fitting mounted at the proximate end of the catheter.
3. A vascular dilation catheter as in claim
20 1, further including a flexible reinforcement tube located over the inner tubular wall.
4. A vascular dilation catheter as in claim 3, wherein the flexible reinforcement tube is composed 5 of a material selected from the group consisting of nylon, polyethylenes, polyolefins, polyvinylchlorides, and polyurethanes.
5. A vascular dilation catheter as in claim 0 1, wherein the inner and outer tubular walls are composed of a material selected from the group consisting of cross-linked polyolefins and halocarbon polymers.
5
6. A vascular dilation catheter as in claim 1, having a length in the range from about 40 to
150 cm, a central lumen diameter in the range from 165
22 about 0.25 to 1.5 mm., an outside tube diameter in the range from about 0.5 to 2 mm.
7. A vascular dilation catheter as in claim i7 wherein the dilation balloon has an outside diameter in the range from about 1 to 30 mm and a length in the range from about 1 to 20 cm.
8. A vascular dilation catheter as in claim 1, wherein the means for directing an inflation medium is defined by an annular lumen between the inner and outer tubular wall, which lumen extends from the 'dilation balloon to the proximate end of the catheter.
9. A vascular dilation catheter as in claim
1, wherein the means for directing an inflation medium is defined by one or more axial lumens extending
* through the inner tubular wall, with said' outer tubular wall conforming to the inner tubular wall.
10. A vascular dilation catheter as in claim 1, wherein the means for directing an inflation medium, is defined by one or more axial lumens extending through the outer tubular wall, with said outer tubular wall conforming to the inner tubular wall.
11. A vascular dilation catheter as in claim 1, wherein the flexible tube is reinforced in the region of the balloon.
12. A vascular dilation catheter comprising: a flexible tube having proximate and distal ends and an axial lumen extending between said proximate and distal ends; a flexible sheath extending through the lumen from the proximate end to the distal end, folding back over the exterior of the tube at the distal end, and 23 extending over the exterior to the proximate end to form an annular space between the exterior of the tube and the sheath, said annular space including a first enlarged region proximate the distal end which defines 5 a dilation balloon and a second narrower region between the first region and the proximate end which defines a conduit for directing inflation medium to the dilation balloon.
° 13. A vascular dilation catheter as in claim
12, further including a fitting mounted at the proximate end of the catheter.
14. A vascular dilation catheter as in claim 5 12, wherein the flexible tube is a thermoplastic material extruded over the portion of the sheath which extends through the lumen of the flexible tube.
15. A vascular dilation catheter as in claim 0 14, wherein the thermoplastic material is selected from the group consisting of nylon, polyethylenes, polyolefins, polyvinylchlorides, and polyurethanes.
16. A vascular dilation catheter as in claim i2, wherein the sheath is composed of a cross-linked polyolefin or a halocarbon polymer.
17. A vascular dilation catheter as in claim 12, having a length in the range from about 40 to 150 cm, a central lumen diameter in the range from about 0.25 to 1.5 mm., an outside tube diameter in the range from about 0.5 to 2 mm.
18. A vascular dilation catheter as in claim 12, wherein the dilation balloon has an outside diameter in the range from about 1 to 30 mm. and a length in the range from about 1 to 20 cm. 165
24
19. A vascular dilation catheter as in claim 12, wherein the flexible tube is a laminate construction of at least two materials.
20. A vascular dilation catheter as in claim
12, wherein the flexible reinforcement tube comprises a polyurethane and the sheath comprises a cross-linked polyolefin or a halocarbon polymer.
21. A method for fabricating a vascular dilation catheter, said method comprising: forming an elongate tubular member from a preselected thermoplastic material; expanding a first segment of the elongate tubular member to an inside diameter greater than the outside diameter of the remainder thereof; folding the expanded first segment of the -tubular member back over the remainder thereof to form an involuted structure having an outer wall defined by the first segment and an inner wall defined by the remainder; and * adjusting the diameter of the outer wall proximate the area of folding to define a dilation balloon.
22. A method as in claim 21, wherein a flexible reinforcement tube is formed by extrusion over the remainder of the tubular member prior to folding.
23. A method as in claim 22, wherein the flexible reinforcement tube is composed of a thermoplastic selected from the group consisting of nylon, polyethylenes, polyolefins, polyvinylchlorides, polyurethanes, and halocarbon polymers. 25
24. A method as in claim 23, wherein the thermoplastic material of the elongate tubular member is a halocarbon polymer.
25. A method as in claim 24, wherein the thermoplastic material of the elongate tubular member is a cross-linked polyolefin.
26. A method as in claim 21, wherein the elongate tubular member is expanded by raising its temperature above the crystalline melting point of the thermoplastic, applying internal pressure to enlarge the first segment to a preselected diameter, and cooling the tubular member to retain its shape.
27. A method as in claim 26, wherein the preselected diameter.corresponds to the desired diameter of the dilation balloon.
28. A method as in claim 27, wherein the first portion of the tubular member except for the dilation balloon is thereafter shrunk by localized heating.
29. A method as in claim 28, wherein a mandrel is inserted between the outer and inner walls during the localized heating in order to precisely control the internal diameter of the first portion of the tubular member which corresponds to the outer wall.
30. An improved vascular catheter of the type including a dilation balloon at its distal end, said improvement comprising a substantially flat face defined by the balloon at the distal end of the catheter. 65
26
31. A vascular catheter comprising: an inner and an outer tubular wall formed as a continuous involuted structure having proximate and distal ends; a dilation balloon defined by an expanded portion of the outer tubular wall at the distal end of the continuous, involuted structure; means for directing an inflation medium from the proximate end of the structure to the dilation balloon; and means for heating inflation medium within the dilation balloon.
32. A vascular catheter as in claim 31, wherein the means for heating inflation medium includes a laser energy source and a fiber optic waveguide coupled to the laser energy source for delivering heating energy to the dilation balloon.
33. A vascular catheter as in claim 32, wherein the means for heating the inflation medium further includes means for diffusing laser energy within the dilation balloon.
34. A vascular catheter as in claim 31, wherein the means for heating inflation medium includes a resistance heater within the dilation balloon and means for electrically coupling the resistance heater to a power source external to the catheter.
35. A vascular as in claim 31, wherein the continuous involuted structure is composed of a thermoplastic.
36. A vascular catheter as in claim 35, wherein the thermoplastic is a halocarbon polymer. 27
37. A vascular catheter as in claim 36, wherein the halocarbon polymer is selected from the group consisting of polytetrafluoroethylene, polymers of fluorinated ethylene propylene, polymers of chlorotrifluoroethylene, polyvinylidene fluoride, and hexafluoropropylene polymers.
38. A vascular catheter as in claim 31, wherein the means for directing an inflation medium is defined by an annular lumen between the inner tube and the outer tube, which lumen extends from the dilation balloon to the proximate end of the catheter.
39. A vascular catheter as in claim 31, wherein the means for directing an inflation medium includes a discrete lumen extending from the proximate end of the catheter to the balloon and wherein the outer tube conforms to the exterior of the inner tube except at the inflation balloon.
40. A vascular catheter as in claim 31, further including means for dividing the internal, volume of the balloon into a plurality of separate compartments.
41. A vascular catheter as in claim 40, wherein the means for heating inflation medium selectively heats one or more of the separate compartments.
42. A vascular catheter as in claim 31, wherein the enlarged portion of the outer tubular wall which defines the dilation balloon has included thinned regions which are capable of enhanced heat transfer.
43. A method for ablating stenosis within a blood vessel, said method comprising: 65
28 introducing a balloon dilation catheter into the blood vessel so that the balloon lies adjacent the stenosis; inflating the balloon; heating the inflation medium within the balloon to a preselected minimum temperature; and leaving the balloon in contact with the stenosis for a time sufficient to achieve ablation.
44. A method as in claim 43, wherein the minimum temperature is about 120*C and the contact time is at least about 10 seconds.
45. A method as in claim 43, wherein the minimum contact time is about 5 seconds and the temperature is at least about 180*C.
46. A method as in claim 43, wherein he dilation balloon is formed from a fluorocarbon polymer.
47. A method as in claim 46, wherein the halocarbon polymer is selected from the group consisting of polytetrafluoroethylene, polymers of fluorinated ethylene propylene, polymers of chlorotrifluoroethylene, polyvinylidene fluoride, and hexafluoropropylene polymers.
48'. A method as in claim 43, wherein the balloon is inflated to a pressure of at least about 10 psi.
49. A method as in claim 43, wherein the inflation medium is heated by laser energy.
50. A method as in claim 43, wherein the inflation medium is heated by an electrical resistance heater. 29
51. A method as in claim 43, wherein a portion of the- inflation medium within the balloon is selectively heated, whereby heat may be non-uniformly delivered to the stenosis.
52. A method as in claim 43, wherein the dilation balloon is divided into separate compartments and the inflation medium within selected ones of said compartments is heated.
53. A method as in claim 43, wherein a portion of the dilation balloon wall is thinned relative to the remaining wall, whereby heat transfer through said thinned portion is enhanced.
PCT/US1988/004384 1987-12-11 1988-12-08 Improved vascular dilation catheter construction WO1989005165A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13177587A 1987-12-11 1987-12-11
US131,775 1987-12-11
US07/242,012 US5041089A (en) 1987-12-11 1988-09-08 Vascular dilation catheter construction
US242,012 1988-09-08

Publications (1)

Publication Number Publication Date
WO1989005165A1 true WO1989005165A1 (en) 1989-06-15

Family

ID=26829784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/004384 WO1989005165A1 (en) 1987-12-11 1988-12-08 Improved vascular dilation catheter construction

Country Status (3)

Country Link
US (1) US5041089A (en)
AU (1) AU2793189A (en)
WO (1) WO1989005165A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041089A (en) * 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
EP0490979A1 (en) * 1989-09-08 1992-06-24 Boston Scient Corp Physiologic low stress angioplasty.
ES2914838A1 (en) * 2022-01-07 2022-06-16 Conic Vascular Espana Sl Thermal balloon for stenosis treatment (Machine-translation by Google Translate, not legally binding)
WO2022243688A1 (en) * 2021-05-19 2022-11-24 The Flume Catheter Company Limited Urinary catheter and methods of manufacture

Families Citing this family (264)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006119A (en) * 1989-05-25 1991-04-09 Engineering & Research Associates, Inc. Hollow core coaxial catheter
US5364357A (en) * 1989-09-25 1994-11-15 Schneider (Usa) Inc. Small diameter dilatation catheter having wire reinforced coaxial tubular body
DK0420488T3 (en) 1989-09-25 1993-08-30 Schneider Usa Inc Multilayer extrusion as a method for preparing angioplasty balloons
DE9016985U1 (en) * 1990-03-05 1991-03-07 Schneider (Europe) Ag, Zuerich, Ch
US20030216761A1 (en) * 1990-03-27 2003-11-20 Samuel Shiber Guidewire system
US5624392A (en) 1990-05-11 1997-04-29 Saab; Mark A. Heat transfer catheters and methods of making and using same
US5100424A (en) * 1990-05-21 1992-03-31 Cardiovascular Imaging Systems, Inc. Intravascular catheter having combined imaging abrasion head
US5190540A (en) * 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5423754A (en) * 1990-09-20 1995-06-13 Scimed Life Systems, Inc. Intravascular catheter
EP0567549B1 (en) * 1991-01-14 1998-06-24 Kontron Instruments, Inc. Durable and flexible catheter or central lumen having a low kink radius
US5254090A (en) * 1991-01-14 1993-10-19 Kontron Instruments, Inc. Balloon catheter having a dual layer inner member
US5195969A (en) 1991-04-26 1993-03-23 Boston Scientific Corporation Co-extruded medical balloons and catheter using such balloons
US5171305A (en) * 1991-10-17 1992-12-15 Imagyn Medical, Inc. Linear eversion catheter with reinforced inner body extension
CA2091921C (en) * 1992-03-30 1999-06-01 Ronald J. Solar Inflatable catheter system
US5562720A (en) * 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5277201A (en) * 1992-05-01 1994-01-11 Vesta Medical, Inc. Endometrial ablation apparatus and method
US5443470A (en) * 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US6623516B2 (en) * 1992-08-13 2003-09-23 Mark A. Saab Method for changing the temperature of a selected body region
US5315747A (en) * 1992-10-30 1994-05-31 Pameda N.V. Method of preparing a balloon dilatation catheter
US5531690A (en) * 1992-10-30 1996-07-02 Cordis Corporation Rapid exchange catheter
US5336178A (en) * 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5536250A (en) * 1994-04-01 1996-07-16 Localmed, Inc. Perfusion shunt device and method
US5571122A (en) 1992-11-09 1996-11-05 Endovascular Instruments, Inc. Unitary removal of plaque
US5643297A (en) 1992-11-09 1997-07-01 Endovascular Instruments, Inc. Intra-artery obstruction clearing apparatus and methods
US5318228A (en) * 1992-12-15 1994-06-07 Neos Technology Inc. Sodium dispersion and organohalide reaction processes
US6110168A (en) * 1993-02-10 2000-08-29 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications
US5837003A (en) * 1993-02-10 1998-11-17 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US6033383A (en) * 1996-12-19 2000-03-07 Ginsburg; Robert Temperature regulating catheter and methods
US5486208A (en) * 1993-02-10 1996-01-23 Ginsburg; Robert Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US6620188B1 (en) 1998-08-24 2003-09-16 Radiant Medical, Inc. Methods and apparatus for regional and whole body temperature modification
US6849083B2 (en) * 1993-02-10 2005-02-01 Radiant Medical, Inc. Method and apparatus for controlling a patients's body temperature by in situ blood temperature modification
US5354518A (en) * 1993-02-11 1994-10-11 Sherwood Medical Company Method for manufacturing a fiberscopic catheter
AU3774193A (en) * 1993-02-23 1994-09-14 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5429136A (en) * 1993-04-21 1995-07-04 Devices For Vascular Intervention, Inc. Imaging atherectomy apparatus
US5617870A (en) * 1993-04-29 1997-04-08 Scimed Life Systems, Inc. Intravascular flow measurement system
US5346508A (en) * 1993-04-29 1994-09-13 Scimed Life Systems, Inc. Apparatus and method for performing diagnostics and intravascular therapies
US5405322A (en) * 1993-08-12 1995-04-11 Boston Scientific Corporation Method for treating aneurysms with a thermal source
US5462529A (en) * 1993-09-29 1995-10-31 Technology Development Center Adjustable treatment chamber catheter
US6896842B1 (en) 1993-10-01 2005-05-24 Boston Scientific Corporation Medical device balloons containing thermoplastic elastomers
EP0738168B1 (en) 1993-10-01 2004-01-21 Boston Scientific Corporation Medical device balloons containing thermoplastic elastomers
US5961765A (en) * 1994-09-20 1999-10-05 Schneider (Europe) A. G. Method of making a catheter
DK0650740T3 (en) * 1993-10-27 1999-12-20 Schneider Europ Gmbh intervention catheter
US6659977B2 (en) * 1993-10-27 2003-12-09 Schneider (Europe) A.G. Multilayer interventional catheter
WO1995016141A1 (en) * 1993-12-09 1995-06-15 Devices For Vascular Intervention, Inc. Composite drive shaft
US5562620A (en) * 1994-04-01 1996-10-08 Localmed, Inc. Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon
US5599306A (en) * 1994-04-01 1997-02-04 Localmed, Inc. Method and apparatus for providing external perfusion lumens on balloon catheters
US5470322A (en) * 1994-04-15 1995-11-28 Danforth Biomedical Inc. Reinforced multilumen catheter for axially varying stiffness
US5499632A (en) * 1994-05-04 1996-03-19 Devices For Vascular Intervention Guide wire migration controller
US5919161A (en) * 1994-05-04 1999-07-06 Devices For Vascular Intervention Guidewire migration controller
US6007483A (en) * 1994-06-01 1999-12-28 Archimedes Surgical, Inc. Surgical method for developing an anatomic structure
US5569183A (en) * 1994-06-01 1996-10-29 Archimedes Surgical, Inc. Method for performing surgery around a viewing space in the interior of the body
US5658306A (en) * 1994-07-01 1997-08-19 Archimedes Surgical, Inc. Method for making additional incisions in laparoscopic surgery
US5624381A (en) * 1994-08-09 1997-04-29 Kieturakis; Maciej J. Surgical instrument and method for retraction of an anatomic structure defining an interior lumen
US5749851A (en) * 1995-03-02 1998-05-12 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5601581A (en) * 1995-05-19 1997-02-11 General Surgical Innovations, Inc. Methods and devices for blood vessel harvesting
US5979452A (en) * 1995-06-07 1999-11-09 General Surgical Innovations, Inc. Endoscopic linton procedure using balloon dissectors and retractors
US5653689A (en) * 1995-09-30 1997-08-05 Abacus Design & Development, Inc. Infusion catheter
EP1287845B1 (en) 1996-04-26 2006-05-31 Schneider (Europe) GmbH Interventional catheter
US5769817A (en) * 1997-02-28 1998-06-23 Schneider (Usa) Inc. Coextruded balloon and method of making same
US6165166A (en) * 1997-04-25 2000-12-26 Schneider (Usa) Inc. Trilayer, extruded medical tubing and medical devices incorporating such tubing
US6923803B2 (en) * 1999-01-15 2005-08-02 Gyrus Medical Limited Electrosurgical system and method
US5971979A (en) 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia
AU2023099A (en) 1997-12-31 1999-07-19 Jack W. Romano Method and apparatus for transferring drilling energy to a cutting member
US6096068A (en) * 1998-01-23 2000-08-01 Innercool Therapies, Inc. Selective organ cooling catheter and method of using the same
US6383210B1 (en) 2000-06-02 2002-05-07 Innercool Therapies, Inc. Method for determining the effective thermal mass of a body or organ using cooling catheter
US6231595B1 (en) 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US6261312B1 (en) 1998-06-23 2001-07-17 Innercool Therapies, Inc. Inflatable catheter for selective organ heating and cooling and method of using the same
US6325818B1 (en) 1999-10-07 2001-12-04 Innercool Therapies, Inc. Inflatable cooling apparatus for selective organ hypothermia
US6245095B1 (en) 1998-03-24 2001-06-12 Innercool Therapies, Inc. Method and apparatus for location and temperature specific drug action such as thrombolysis
US6254626B1 (en) 1998-03-24 2001-07-03 Innercool Therapies, Inc. Articulation device for selective organ cooling apparatus
US6238428B1 (en) 1998-01-23 2001-05-29 Innercool Therapies, Inc. Selective organ cooling apparatus and method employing turbulence-inducing element with curved terminations
US6471717B1 (en) 1998-03-24 2002-10-29 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6558412B2 (en) 1998-01-23 2003-05-06 Innercool Therapies, Inc. Selective organ hypothermia method and apparatus
US7371254B2 (en) 1998-01-23 2008-05-13 Innercool Therapies, Inc. Medical procedure
US6991645B2 (en) 1998-01-23 2006-01-31 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6312452B1 (en) 1998-01-23 2001-11-06 Innercool Therapies, Inc. Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device
US6491039B1 (en) 1998-01-23 2002-12-10 Innercool Therapies, Inc. Medical procedure
US6585752B2 (en) 1998-06-23 2003-07-01 Innercool Therapies, Inc. Fever regulation method and apparatus
US6843800B1 (en) 1998-01-23 2005-01-18 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6251130B1 (en) 1998-03-24 2001-06-26 Innercool Therapies, Inc. Device for applications of selective organ cooling
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
US6051019A (en) 1998-01-23 2000-04-18 Del Mar Medical Technologies, Inc. Selective organ hypothermia method and apparatus
US6251129B1 (en) 1998-03-24 2001-06-26 Innercool Therapies, Inc. Method for low temperature thrombolysis and low temperature thrombolytic agent with selective organ temperature control
US6379378B1 (en) 2000-03-03 2002-04-30 Innercool Therapies, Inc. Lumen design for catheter
US6491716B2 (en) 1998-03-24 2002-12-10 Innercool Therapies, Inc. Method and device for applications of selective organ cooling
US6464716B1 (en) 1998-01-23 2002-10-15 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US20050131453A1 (en) * 1998-03-13 2005-06-16 Parodi Juan C. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6960222B2 (en) * 1998-03-13 2005-11-01 Gore Enterprise Holdins, Inc. Catheter having a funnel-shaped occlusion balloon of uniform thickness and methods of manufacture
US6599312B2 (en) 1998-03-24 2003-07-29 Innercool Therapies, Inc. Isolated selective organ cooling apparatus
US6576002B2 (en) 1998-03-24 2003-06-10 Innercool Therapies, Inc. Isolated selective organ cooling method and apparatus
US6551349B2 (en) 1998-03-24 2003-04-22 Innercool Therapies, Inc. Selective organ cooling apparatus
US6224624B1 (en) 1998-03-24 2001-05-01 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6685732B2 (en) 1998-03-31 2004-02-03 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US7001378B2 (en) 1998-03-31 2006-02-21 Innercool Therapies, Inc. Method and device for performing cooling or cryo-therapies, for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US6602276B2 (en) 1998-03-31 2003-08-05 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US7291144B2 (en) 1998-03-31 2007-11-06 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US6905494B2 (en) 1998-03-31 2005-06-14 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US6589271B1 (en) 1998-04-21 2003-07-08 Alsius Corporations Indwelling heat exchange catheter
US6419643B1 (en) 1998-04-21 2002-07-16 Alsius Corporation Central venous catheter with heat exchange properties
US6368304B1 (en) 1999-02-19 2002-04-09 Alsius Corporation Central venous catheter with heat exchange membrane
US6126684A (en) 1998-04-21 2000-10-03 The Regents Of The University Of California Indwelling heat exchange catheter and method of using same
US6716236B1 (en) 1998-04-21 2004-04-06 Alsius Corporation Intravascular catheter with heat exchange element having inner inflation element and methods of use
US6458150B1 (en) * 1999-02-19 2002-10-01 Alsius Corporation Method and apparatus for patient temperature control
US8128595B2 (en) 1998-04-21 2012-03-06 Zoll Circulation, Inc. Method for a central venous line catheter having a temperature control system
US6338727B1 (en) 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6908474B2 (en) * 1998-05-13 2005-06-21 Gore Enterprise Holdings, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6450990B1 (en) 1998-08-13 2002-09-17 Alsius Corporation Catheter with multiple heating/cooling fibers employing fiber spreading features
US6673098B1 (en) * 1998-08-24 2004-01-06 Radiant Medical, Inc. Disposable cassette for intravascular heat exchange catheter
US6620189B1 (en) 2000-02-28 2003-09-16 Radiant Medical, Inc. Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter
US20020007145A1 (en) * 1998-10-23 2002-01-17 Timothy Stivland Catheter having improved bonding region
US6955661B1 (en) 1999-01-25 2005-10-18 Atrium Medical Corporation Expandable fluoropolymer device for delivery of therapeutic agents and method of making
US6869440B2 (en) 1999-02-09 2005-03-22 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
US6830581B2 (en) 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
US6299599B1 (en) 1999-02-19 2001-10-09 Alsius Corporation Dual balloon central venous line catheter temperature control system
US6405080B1 (en) 1999-03-11 2002-06-11 Alsius Corporation Method and system for treating cardiac arrest
US6582398B1 (en) 1999-02-19 2003-06-24 Alsius Corporation Method of managing patient temperature with a heat exchange catheter
US6428534B1 (en) 1999-02-24 2002-08-06 Cryovascular Systems, Inc. Cryogenic angioplasty catheter
US6648879B2 (en) 1999-02-24 2003-11-18 Cryovascular Systems, Inc. Safety cryotherapy catheter
US6432102B2 (en) 1999-03-15 2002-08-13 Cryovascular Systems, Inc. Cryosurgical fluid supply
US6514245B1 (en) 1999-03-15 2003-02-04 Cryovascular Systems, Inc. Safety cryotherapy catheter
US6165207A (en) * 1999-05-27 2000-12-26 Alsius Corporation Method of selectively shaping hollow fibers of heat exchange catheter
US6287326B1 (en) 1999-08-02 2001-09-11 Alsius Corporation Catheter with coiled multi-lumen heat transfer extension
US6447474B1 (en) * 1999-09-15 2002-09-10 Alsius Corporation Automatic fever abatement system
US6221042B1 (en) 1999-09-17 2001-04-24 Scimed Life Systems, Inc. Balloon with reversed cones
US7097641B1 (en) * 1999-12-09 2006-08-29 Cryocath Technologies Inc. Catheter with cryogenic and heating ablation
US6440125B1 (en) 2000-01-04 2002-08-27 Peter Rentrop Excimer laser catheter
US7947059B2 (en) 2000-03-02 2011-05-24 Boston Scientific Scimed, Inc. Multilayer medical device
US6726708B2 (en) 2000-06-14 2004-04-27 Innercool Therapies, Inc. Therapeutic heating and cooling via temperature management of a colon-inserted balloon
US6602246B1 (en) 2000-08-18 2003-08-05 Cryovascular Systems, Inc. Cryotherapy method for detecting and treating vulnerable plaque
US6955174B2 (en) * 2000-08-18 2005-10-18 Uryovascular Systems, Inc. Cryotherapy method for detecting and treating vulnerable plaque
US20020147462A1 (en) * 2000-09-11 2002-10-10 Closure Medical Corporation Bronchial occlusion method and apparatus
DE10105592A1 (en) 2001-02-06 2002-08-08 Achim Goepferich Placeholder for drug release in the frontal sinus
EP1258230A3 (en) 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
US6676692B2 (en) * 2001-04-27 2004-01-13 Intek Technology L.L.C. Apparatus for delivering, repositioning and/or retrieving self-expanding stents
US6752786B2 (en) * 2001-05-31 2004-06-22 Radiant Medical, Inc. Moving heat exchange catheter system
US6786900B2 (en) 2001-08-13 2004-09-07 Cryovascular Systems, Inc. Cryotherapy methods for treating vessel dissections and side branch occlusion
WO2003015672A1 (en) 2001-08-15 2003-02-27 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering
US6572640B1 (en) 2001-11-21 2003-06-03 Alsius Corporation Method and apparatus for cardiopulmonary bypass patient temperature control
US7018346B2 (en) 2001-12-18 2006-03-28 Scimed Life Systems, Inc. Guide wire with adjustable flexibility
US6884342B2 (en) * 2002-02-28 2005-04-26 Bioprocess Technologies Ltd. Wastewater trickle tower biomedia strands arrangement
TWI235073B (en) * 2002-08-20 2005-07-01 Toray Industries Catheter for treating cardiac arrhythmias
US6780183B2 (en) * 2002-09-16 2004-08-24 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
US8317816B2 (en) * 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
US7488339B2 (en) * 2002-10-21 2009-02-10 Boston Scientific Scimed, Inc. Multilayer medical device
US7378048B2 (en) * 2002-12-03 2008-05-27 Boston Scientific Scimed, Inc. Method for forming catheter curves
US7278984B2 (en) 2002-12-31 2007-10-09 Alsius Corporation System and method for controlling rate of heat exchange with patient
US6951675B2 (en) * 2003-01-27 2005-10-04 Scimed Life Systems, Inc. Multilayer balloon catheter
US7300453B2 (en) 2003-02-24 2007-11-27 Innercool Therapies, Inc. System and method for inducing hypothermia with control and determination of catheter pressure
US7072460B2 (en) * 2003-05-27 2006-07-04 Vtech Telecommunications Limited System and method for retrieving telephone numbers
US7060062B2 (en) * 2003-06-04 2006-06-13 Cryo Vascular Systems, Inc. Controllable pressure cryogenic balloon treatment system and method
US20050027309A1 (en) * 2003-06-17 2005-02-03 Samuel Shiber Guidewire system
US20050177073A1 (en) * 2003-06-17 2005-08-11 Samuel Shiber Guidewire system with a deflectable distal tip
US20050143768A1 (en) * 2003-06-17 2005-06-30 Samuel Shiber Sleeved guidewire system method of use
US8146400B2 (en) * 2004-04-21 2012-04-03 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US8177779B2 (en) * 2004-06-02 2012-05-15 Boston Scientific Scimed, Inc. Controllable pressure cryogenic balloon treatment system and method
US7399291B2 (en) * 2004-12-02 2008-07-15 Syntheon, Llc. Catheter for treatment of total occlusions and methods for manufacture and use of the catheter
US7828790B2 (en) * 2004-12-03 2010-11-09 Boston Scientific Scimed, Inc. Selectively flexible catheter and method of use
US7604631B2 (en) * 2004-12-15 2009-10-20 Boston Scientific Scimed, Inc. Efficient controlled cryogenic fluid delivery into a balloon catheter and other treatment devices
US20060149136A1 (en) * 2004-12-22 2006-07-06 Kyphon Inc. Elongating balloon device and method for soft tissue expansion
US20060270981A1 (en) * 2005-05-13 2006-11-30 Leonilda Capuano Coiled injection tube
US8992515B2 (en) * 2005-05-13 2015-03-31 Medtronic Cryocath Lp Coolant injection tube
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US20060282149A1 (en) 2005-06-08 2006-12-14 Xtent, Inc., A Delaware Corporation Apparatus and methods for deployment of multiple custom-length prostheses (II)
US8951225B2 (en) * 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
JP4648785B2 (en) * 2005-07-20 2011-03-09 Hoya株式会社 Endoscopic balloon catheter for endoscope
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
US9345509B2 (en) * 2006-02-22 2016-05-24 Baylis Medical Company Inc. Guide-wire dilation device for facilitation of lesion crossing
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
CA2659829A1 (en) * 2006-05-26 2007-12-06 Bruce B. Becker Nasolacrimal system surgical tool and method
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
US8622911B2 (en) * 2007-10-26 2014-01-07 University Of Virginia Patent Foundation System for treatment and imaging using ultrasonic energy and microbubbles and related method thereof
US9895158B2 (en) 2007-10-26 2018-02-20 University Of Virginia Patent Foundation Method and apparatus for accelerated disintegration of blood clot
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
WO2009108816A1 (en) * 2008-02-26 2009-09-03 Boston Scientific Scimed, Inc. Balloon catheter with durable tip portion
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
US8951545B2 (en) 2008-03-28 2015-02-10 Surmodics, Inc. Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
US9364349B2 (en) 2008-04-24 2016-06-14 Surmodics, Inc. Coating application system with shaped mandrel
JP5676446B2 (en) 2008-07-30 2015-02-25 アクラレント インコーポレイテッド Sinus mouth finder
US8845627B2 (en) * 2008-08-22 2014-09-30 Boston Scientific Scimed, Inc. Regulating pressure to lower temperature in a cryotherapy balloon catheter
US8216498B2 (en) 2008-09-10 2012-07-10 Boston Scientific Scimed, Inc. Catheter having a coextruded fluoropolymer layer
AU2009293312B2 (en) 2008-09-18 2015-07-09 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
JP5726084B2 (en) * 2008-11-11 2015-05-27 シファメド・ホールディングス・エルエルシー Thin electrode assembly
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
CN102427834A (en) * 2009-04-28 2012-04-25 苏尔莫迪克斯公司 Devices and methods for delivery of bioactive agents
US8235981B2 (en) * 2009-06-02 2012-08-07 Vivant Medical, Inc. Electrosurgical devices with directional radiation pattern
EP2445568B1 (en) 2009-06-24 2020-09-23 Kalila Medical, Inc. Steerable medical delivery devices
KR101109700B1 (en) * 2009-09-07 2012-01-31 신경민 Kadeteo prayer balloons
CA2793737A1 (en) 2010-03-24 2011-09-29 Shifamed Holdings, Llc Intravascular tissue disruption
US8440090B2 (en) 2010-04-29 2013-05-14 Abbott Cardiovascular Systems Inc. Apparatus and method of making a variable stiffness multilayer catheter tubing
WO2011143468A2 (en) 2010-05-12 2011-11-17 Shifamed, Llc Low profile electrode assembly
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
EP2588157B1 (en) 2010-06-30 2020-03-18 SurModics, Inc. Lipid coating for medical devices delivering bioactive agent
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
WO2012096787A1 (en) 2010-12-30 2012-07-19 Surmodics, Inc. Double wall catheter for delivering therapeutic agent
US20120172796A1 (en) 2010-12-30 2012-07-05 Chappa Ralph A Composition for intravascular delivery of therapeutic composition
WO2012151396A2 (en) 2011-05-03 2012-11-08 Shifamed Holdings, Llc Steerable delivery sheaths
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
EP3012301B1 (en) 2012-01-18 2023-08-16 SurModics, Inc. Lubricious medical device coating with low particulates
US8961550B2 (en) 2012-04-17 2015-02-24 Indian Wells Medical, Inc. Steerable endoluminal punch
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
MX351261B (en) 2012-06-01 2017-10-06 Surmodics Inc Apparatus and method for coating balloon catheters.
CA2889062C (en) 2012-10-25 2022-06-21 Surmodics, Inc. Apparatus and methods for coating medical devices
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
JP6438406B2 (en) 2012-11-05 2018-12-12 サーモディクス,インコーポレイテッド Compositions and methods for delivering hydrophobic bioactive agents
US9283350B2 (en) 2012-12-07 2016-03-15 Surmodics, Inc. Coating apparatus and methods
US9278023B2 (en) 2012-12-14 2016-03-08 Zoll Circulation, Inc. System and method for management of body temperature
EP2941279B1 (en) 2013-01-04 2023-05-17 SurModics, Inc. Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9814488B2 (en) 2013-03-15 2017-11-14 Globus Medical, Inc. Surgical probe incorporating a dilator
CN110141177B (en) 2013-04-08 2021-11-23 阿帕玛医疗公司 Ablation catheter
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
US10349824B2 (en) 2013-04-08 2019-07-16 Apama Medical, Inc. Tissue mapping and visualization systems
WO2014182833A2 (en) 2013-05-07 2014-11-13 Surmodics, Inc. Apparatus and methods for coating medical devices
US10124088B2 (en) 2014-09-29 2018-11-13 Surmodics, Inc. Lubricious medical device elements
EP3244960B1 (en) 2015-01-14 2024-01-10 SurModics, Inc. Insertion tools for medical device
JP6783780B2 (en) 2015-02-26 2020-11-11 サーモディクス,インコーポレイティド Insertable medical device system with plaque treatment part and how to use it
WO2016160694A1 (en) 2015-03-27 2016-10-06 Shifamed Holdings, Llc Steerable medical devices, systems, and methods of use
EP3285849A4 (en) 2015-04-24 2018-12-26 Shifamed Holdings, LLC Steerable medical devices, systems, and methods of use
US10478546B2 (en) 2015-09-15 2019-11-19 Surmodics, Inc. Hemodialysis catheter sleeve
WO2017083257A1 (en) 2015-11-09 2017-05-18 Shifamed Holdings, Llc Steering assemblies for medical devices, and methods of use
WO2017087549A1 (en) 2015-11-16 2017-05-26 Apama Medical, Inc. Energy delivery devices
US10342898B2 (en) 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
WO2017173121A1 (en) 2016-03-31 2017-10-05 Surmodics, Inc. Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
US10918835B2 (en) 2016-03-31 2021-02-16 Surmodics, Inc. Delivery system for active agent coated balloon
CN110198756B (en) 2016-09-16 2022-07-12 舒尔默迪克斯公司 Lubricious insertion tool for medical devices and methods of using same
US11123459B2 (en) 2016-12-16 2021-09-21 Surmodics, Inc. Hydrophobic active agent particle coatings and methods for treatment
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
US11478815B2 (en) 2020-01-16 2022-10-25 Surmodics, Inc. Coating systems for medical devices

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911927A (en) * 1974-04-17 1975-10-14 Princeton Biomedix Eversible catheter
US4323071A (en) * 1978-04-24 1982-04-06 Advanced Catheter Systems, Inc. Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods of making the same
US4470407A (en) * 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
US4479497A (en) * 1982-11-12 1984-10-30 Thomas J. Fogarty Double lumen dilatation catheter
US4526175A (en) * 1983-02-22 1985-07-02 Thomas J. Fogarty Double lumen dilatation catheter
US4624657A (en) * 1983-11-15 1986-11-25 Medi-Tech, Incorporated Medical devices having inflatable portions
US4754752A (en) * 1986-07-28 1988-07-05 Robert Ginsburg Vascular catheter
US4775371A (en) * 1986-09-02 1988-10-04 Advanced Cardiovascular Systems, Inc. Stiffened dilatation catheter and method of manufacture

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH616337A5 (en) * 1977-10-21 1980-03-31 Schneider Medintag Ag
US4448188A (en) * 1982-02-18 1984-05-15 Laserscope, Inc. Method for providing an oxygen bearing liquid to a blood vessel for the performance of a medical procedure
US4445892A (en) * 1982-05-06 1984-05-01 Laserscope, Inc. Dual balloon catheter device
US4863424A (en) * 1983-11-18 1989-09-05 Blake Joseph W Iii Tubular medical device and method of making and using the same
CA1266412A (en) * 1984-10-24 1990-03-06 J. Richard Spears Method and apparatus for angioplasty
DE3675652D1 (en) * 1985-07-19 1990-12-20 Meadox Medicals Inc EXPANSION CATHETER OR BALLOON CATHETER.
CH668192A5 (en) * 1985-11-29 1988-12-15 Schneider Medintag Ag CATHETER FOR TREATING NARROW BODIES, FOR EXAMPLE IN A BLOOD VESSEL.
US4834093A (en) * 1986-02-03 1989-05-30 Littleford Phillip O Dilation catheter and method
US4817613A (en) * 1987-07-13 1989-04-04 Devices For Vascular Intervention, Inc. Guiding catheter
US4878492A (en) * 1987-10-08 1989-11-07 C. R. Bard, Inc. Laser balloon catheter
US5041089A (en) * 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911927A (en) * 1974-04-17 1975-10-14 Princeton Biomedix Eversible catheter
US4323071A (en) * 1978-04-24 1982-04-06 Advanced Catheter Systems, Inc. Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods of making the same
US4323071B1 (en) * 1978-04-24 1990-05-29 Advanced Cardiovascular System
US4470407A (en) * 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
US4479497A (en) * 1982-11-12 1984-10-30 Thomas J. Fogarty Double lumen dilatation catheter
US4526175A (en) * 1983-02-22 1985-07-02 Thomas J. Fogarty Double lumen dilatation catheter
US4624657A (en) * 1983-11-15 1986-11-25 Medi-Tech, Incorporated Medical devices having inflatable portions
US4754752A (en) * 1986-07-28 1988-07-05 Robert Ginsburg Vascular catheter
US4775371A (en) * 1986-09-02 1988-10-04 Advanced Cardiovascular Systems, Inc. Stiffened dilatation catheter and method of manufacture

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AM J CARDIOL, Vol. 56, 01 December 1985, (HIELE et al.), "Nd-YAG Laser Fusion of Human Plaque-Arterial Wall Separations In Vitro", pages 953-957. *
AM J CARDIOL, Vol. 60, July 1987, (J.R. SPEARS), "Percutaneous Transluminal Angioplasty Restenosis: Potential Prevention with Laser Balloon Angioplasty", pg 61b-64b. *
CARDIOVASC INTERVENT RADIOL, Vol. 9, 1986, (J.R. SPEARS), "Percutaneous Laser Treatment of Athersclerosis: An Overview of Emerging Techniques", pages 303-312. *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041089A (en) * 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
US5496311A (en) * 1988-10-28 1996-03-05 Boston Scientific Corporation Physiologic low stress angioplasty
EP0490979A1 (en) * 1989-09-08 1992-06-24 Boston Scient Corp Physiologic low stress angioplasty.
EP0490979A4 (en) * 1989-09-08 1992-07-29 Boston Scientific Corporation Physiologic low stress angioplasty
WO2022243688A1 (en) * 2021-05-19 2022-11-24 The Flume Catheter Company Limited Urinary catheter and methods of manufacture
ES2914838A1 (en) * 2022-01-07 2022-06-16 Conic Vascular Espana Sl Thermal balloon for stenosis treatment (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
AU2793189A (en) 1989-07-05
US5041089A (en) 1991-08-20

Similar Documents

Publication Publication Date Title
US5041089A (en) Vascular dilation catheter construction
US6966889B2 (en) Multi-lumen catheters and methods for using same
US5662608A (en) Low profile balloon catheter and method
US5423754A (en) Intravascular catheter
EP0944408B1 (en) Infusion balloon catheter
US5342301A (en) Multi-lumen balloons and catheters made therewith
US6440158B1 (en) Heat transfer catheter apparatus and method of making and using same
US5833706A (en) Single operator exchange perfusion catheter having a distal catheter shaft section
EP0540858B1 (en) Inflatable member having elastic expansion with limited range
US6740191B2 (en) Through-transmission welding of catheter components
US5569184A (en) Delivery and balloon dilatation catheter and method of using
US5395333A (en) Multi-lobed support balloon catheter with perfusion
CA2133698C (en) Interventional catheter
US5667493A (en) Dilation catheter
US4822345A (en) Controllable flexibility catheter
CA1333464C (en) Dilatation balloon
US8382935B2 (en) Rapid exchange balloon catheter having a reinforced inner tubular member
EP1023913B1 (en) Balloon catheter and method of production thereof
JP2716584B2 (en) Single lumen small cross-section catheter with valve and balloon
JP2840984B2 (en) catheter
US9381327B2 (en) Balloon catheter
JPH11262529A (en) Balloon catheter
JP2004503304A (en) Method of making a catheter shaft having one or more guidewire ports
JPH0370979B2 (en)
JPH03165780A (en) Catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE